Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.23.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 38,782 $ 32,190
Marketable securities, current 2,889 28,859
Prepaid expenses 2,009 3,459
Grants revenue receivable 2,838 0
Other current assets 5,106 3,790
Total current assets 51,624 68,298
Operating lease right-of-use assets 10,652 11,132
Property and equipment, net 12,814 14,632
Other assets 3,415 3,486
Total assets 78,505 97,548
Current liabilities:    
Accounts payable 2,718 504
Accrued liabilities 5,542 8,823
Deferred revenue, current 19,354 45,573
Other current liabilities 2,286 2,182
Total current liabilities 29,900 57,082
Deferred revenue, long-term 1,156 5,904
Long-term debt, net of current portion 36,402 36,168
Operating lease liabilities 11,635 12,231
Other liabilities 1,322 1,295
Total liabilities 80,415 112,680
Commitments and contingencies (Note 10) 0 0
Stockholders’ deficit    
Preferred stock, $0.001 par value: Authorized: 2,000,000 shares at June 30, 2022 and December 31, 2021; issued and outstanding: 250 shares at June 30, 2022 and December 31, 2021 0 0
Authorized: 150,000,000 shares at March 31, 2023 and December 31, 2022; issued and outstanding: 56,351,647 shares at March 31, 2023 and December 31, 2022 56 56
Additional paid-in capital 431,956 429,646
Accumulated other comprehensive income/(loss) 1 (66)
Accumulated deficit (433,923) (444,768)
Total stockholders’ deficit (1,910) (15,132)
Total liabilities and stockholders’ deficit $ 78,505 $ 97,548